home / stock / plx / plx articles
Leadership Team Strengthened as Clinical Development of LEVI-04 a Novel Neurotrophin Modulator for Osteoarthritis and Chronic Pain Advances SANDWI...
The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around t...
News, Short Squeeze, Breakout and More Instantly...
Protalix BioTherapeutics Inc. Company Name:
PLX Stock Symbol:
NYSE Market:
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout PR Newswire Event will take place on Wednesday, June 26, 2024 in New York CARMIEL, Israel , J...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention PR Newswire Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel , May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc....